Health2Tech

Sergei Polevikov has over two decades of experience in mathematics, statistics, and artificial intelligence, holding four graduate degrees in mathematics, economics, finance, and machine learning.
He has authored more than 30 peer-reviewed publications and manuscripts. His career spans founding successful digital health startups and working as a healthcare fraud investigator.

Today, Sergei is focused on health AI education and science-based truth-telling. He co-hosts the podcast Digital Health Inside Out with Alex Koshykov and runs the Substack AI Health Uncut (sergeiAI.substack.com), which has rapidly grown to nearly 8,000 subscribers within just a few months.

Luca Caruso brings more than 15 years of international experience across Europe and the U.S., specializing in digital health, innovation, and talent strategy.

He began his career in corporate pharma and healthcare before moving into entrepreneurship, where he founded and advised several digital health startups.

His work spans strategy, business growth, and leadership development for companies navigating complex healthcare ecosystems in the U.S., Europe, and the Middle East.

Audrey Guazzone has 15 years of experience in digital health, medical devices, and AI-driven solutions.

She is the founder of LeanLia, a New York–based firm that helps health tech companies enter and grow in the U.S. and Europe through lean, customer-centric strategies.

Her background includes leading French-American innovation and economic development programs, as well as nearly a decade in American tech companies at stages from seed to pre-IPO.
Audrey has driven go-to-market strategies, launched AI-powered health products, managed $20M client portfolios, and built commercial and customer success functions from the ground up.

She currently serves on the boards of Health2Tech and LaTechDMV, where she fosters international ecosystem growth.

Eric Maxwell Brandon holds an M.D. from Ben-Gurion University of the Negev (in collaboration with Columbia University Medical Center), an M.S. in Biochemistry and Molecular Biology with a focus on Entrepreneurial Biotechnology from Georgetown University, and dual B.S. degrees in Applied Mathematics (CUNY) and Integrative Biology (University of Florida).

He currently works as a venture scout for Reduce Labs, a startup venture studio operating between NYC and Israel. In this role, he sources and evaluates high-potential academic research in synthetic biology, neurotechnology, and bio-integrated hardware; conducts technical and commercial diligence; and collaborates with founders on early-stage capital structures and go-to-market strategies.

His combined clinical, molecular, computational, and commercialization expertise enables him to bridge scientific validation with investment readiness in complex life sciences ventures.

Based in Astoria, NYC, Bailey Morgan is a healthtech leader who combines clinical expertise with business strategy to drive healthcare innovation. She earned her Bachelor’s in Communication Sciences and her Master’s in Speech-Language Pathology from St. John’s University in New York.

Bailey began her career as a medical speech-language pathologist in inpatient facilities across NYC, where she saw firsthand the gap between healthcare and other industries in technology adoption. Transitioning into healthtech, she has since raised over $10M in capital, led successful sales and marketing teams through go-to-market stages in both SaaS and CPG, and personally closed more than $2M in technology sales.

Currently, she serves as Chief of Staff at Groth Pain & Spine, overseeing change management and technology integration for a growing network of 10+ locations and 40+ providers.
In addition to consulting for healthcare technology companies, Bailey is Director and Treasurer of a dementia-focused NYC nonprofit that employs individuals living with dementia while supporting families and caregivers.

Her work reflects a consistent commitment to advancing healthcare systems, empowering communities, and scaling innovation.

Linda Alunkal is CEO and Founder of Bitebrave Inc., COO and Co-founder of BioLattice Ophthalmics Inc., and CEO & Principal Consultant of Charted Course Consulting LLC, where her clients include global biotech leader CSL Behring.
She holds an MBA from Temple University and a B.S. in Chemical Engineering from Penn State University.

With over 20 years of experience, Linda has held innovative and transformative roles across Fortune 50 companies and startups, consistently driving business growth and organizational change.
She served in commercialization and regulatory roles within Johnson & Johnson’s World Without Disease Accelerator, and in strategic planning, execution, and program management during the restructuring of J&J’s Global Orthopedics business.
Earlier, she built her expertise in process engineering and supply chain at Sunoco and a hydraulic fracturing startup in the oil and gas sector.

Her professional journey is shaped by her immigrant background and a deep personal mission.
As the mother of children with severe food allergies, Linda has dedicated the past five years to studying the science of food allergy prevention and educating families.

Through Bitebrave, she is committed to helping parents and babies live free from the burden of food allergies.